This track focuses on the latest advancements in diabetes management, including novel therapeutic approaches and technologies. Researchers are invited to present their findings on cutting-edge interventions that improve patient outcomes.

This session will explore the complex relationship between diabetes and cancer, highlighting shared risk factors and potential mechanisms. Contributions should address the implications for prevention and treatment strategies.

This track examines the effects of diabetes on cognitive function and brain health. Papers should investigate the underlying mechanisms and potential interventions to mitigate cognitive decline in diabetic patients.

This session will delve into the cardiovascular complications associated with diabetes, including the role of cardiac resynchronization therapy and implantable devices. Presentations should focus on innovative treatment strategies and outcomes.

This track addresses the prevention and treatment of diabetic foot ulcers, a common complication in diabetes. Researchers are encouraged to share their insights on effective management strategies and novel therapeutic approaches.

This session will focus on the impact of food and nutrition on diabetes management. Contributions should explore dietary strategies, including the role of physical activity and yoga therapy in improving glycemic control.

This track investigates the interplay between obesity and diabetes, including the concept of diabesity. Researchers are invited to present methods for prevention and control of diabetes in obese populations.

This session will highlight the application of bioinformatics tools and techniques in diabetes research. Presentations should focus on data-driven insights that enhance understanding and management of diabetes.

This track will explore the epidemiological trends of diabetes among older adults. Contributions should address the unique challenges and management strategies for this demographic.

This session will examine the role of herbs, supplements, and alternative medicines in diabetes management. Researchers are encouraged to present evidence-based findings on their efficacy and safety.

This track focuses on the development and evaluation of new anti-diabetic agents. Presentations should discuss their mechanisms of action, clinical efficacy, and potential impact on diabetes care.